Develops novel therapeutics for the treatment of multiple myeloma and other cancers
Kesios Therapeutics has raised €27M across 1 funding round from 3 investors, most recently a Series A round in Dec 2015. Based in London, UK; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-12-01 | Series A |
| €27M |
| Abingworth LLP,Imperial Innovations Limited,SV Life Sciences |
| View deal → |
